Market Cap | 1.40B | P/E | - | EPS this Y | -13.80% | Ern Qtrly Grth | - |
Income | -54.96M | Forward P/E | -60.79 | EPS next Y | 28.80% | 50D Avg Chg | -4.00% |
Sales | 235.44M | PEG | -0.33 | EPS past 5Y | - | 200D Avg Chg | -6.00% |
Dividend | N/A | Price/Book | 7.06 | EPS next 5Y | 29.80% | 52W High Chg | -21.00% |
Recommedations | 1.70 | Quick Ratio | 1.63 | Shares Outstanding | 83.54M | 52W Low Chg | 9.00% |
Insider Own | 40.68% | ROA | -8.60% | Shares Float | 39.54M | Beta | 1.00 |
Inst Own | 59.84% | ROE | -31.78% | Shares Shorted/Prior | 7.11M/7.21M | Price | 17.02 |
Gross Margin | 78.39% | Profit Margin | -23.34% | Avg. Volume | 267,703 | Target Price | 14.40 |
Oper. Margin | -17.65% | Earnings Date | Nov 4 | Volume | 231,603 | Change | -1.16% |
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
Piper Sandler | Overweight | Aug 9, 24 |
Needham | Buy | Aug 9, 24 |
JMP Securities | Market Outperform | May 9, 24 |
Piper Sandler | Overweight | May 9, 24 |
Needham | Buy | May 9, 24 |
Stephens & Co. | Overweight | Apr 5, 24 |
Needham | Buy | Apr 4, 24 |
Needham | Buy | Mar 28, 24 |
Piper Sandler | Overweight | Mar 27, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
DaCosta Albert | see remarks see remarks | Nov 10 | Buy | 8.51 | 30,500 | 259,555 | 5,311,110 | 11/13/23 |
SCHNETTLER THOMAS P | Director Director | Jun 14 | Sell | 18.5437 | 6,900 | 127,952 | 29,129 | 06/16/23 |
Friedman Jonathan I | Other Other | Nov 25 | Sell | 20.42 | 15,000 | 306,300 | 52,054 | 06/08/23 |
Friedman Jonathan I | Other Other | Nov 25 | Option | 13.71 | 15,000 | 205,650 | 54,554 | 06/08/23 |
WRIGHT KRISTINA | Director Director | Jun 06 | Sell | 18.5801 | 6,800 | 126,345 | 24,641 | 06/08/23 |
DaCosta Albert | See Remarks See Remarks | Feb 17 | Sell | 17 | 150,000 | 2,550,000 | 25,000 | 02/22/23 |
Jarboe Matthew | Chief Commercial Off.. Chief Commercial Officer | Dec 23 | Sell | 20.93 | 35,110 | 734,852 | 271,764 | 12/27/22 |
Jarboe Matthew | Chief Commercial Off.. Chief Commercial Officer | Dec 23 | Option | 1.2 | 35,110 | 42,132 | 306,874 | 12/27/22 |
Jarboe Matthew | Chief Commercial Off.. Chief Commercial Officer | Dec 20 | Sell | 20.91 | 87,012 | 1,819,421 | 271,764 | 12/23/22 |
Jarboe Matthew | Chief Commercial Off.. Chief Commercial Officer | Dec 20 | Option | 0.8 | 87,012 | 69,610 | 296,677 | 12/23/22 |
MVM Partners LLP | 10% Owner 10% Owner | Dec 19 | Sell | 20.4161 | 9,597 | 195,933 | 139,659,625 | 12/21/22 |
MVM Partners LLP | 10% Owner 10% Owner | Dec 08 | Sell | 20.18 | 44,146 | 890,866 | 13,681,400 | 12/12/22 |
DaCosta Albert | See Remarks See Remarks | Dec 01 | Sell | 19.5141 | 30,000 | 585,423 | 379,136 | 12/02/22 |
MVM Partners LLP | 10% Owner 10% Owner | Nov 23 | Sell | 20.13 | 987 | 19,868 | 13,756,746 | 11/25/22 |
Rosenthal Lee | - - | Nov 07 | Sell | 18.4824 | 61,001 | 1,127,445 | 75,607 | 11/08/22 |
Rosenthal Lee | 10% Owner 10% Owner | Jul 20 | Option | 2.8 | 247,810 | 693,868 | 693,471 | 10/31/22 |
Rosenthal Lee | 10% Owner 10% Owner | Jul 20 | Sell | 18.95 | 691,774 | 13,109,117 | 663,723 | 10/31/22 |
MVM Partners LLP | 10% Owner 10% Owner | Oct 04 | Sell | 19.0936 | 1,517 | 28,965 | 13,876,730 | 10/06/22 |
MVM Partners LLP | 10% Owner 10% Owner | Sep 20 | Sell | 18.68 | 36,421 | 680,344 | 13,878,247 | 09/22/22 |
MVM Partners LLP | 10% Owner 10% Owner | Sep 13 | Sell | 18.93 | 52,810 | 999,693 | 13,922,551 | 09/15/22 |
MVM Partners LLP | 10% Owner 10% Owner | Sep 09 | Sell | 18.88 | 81,231 | 1,533,641 | 13,975,361 | 09/13/22 |
DaCosta Albert | See Remarks See Remarks | Sep 08 | Sell | 18.0069 | 30,000 | 540,207 | 202,890 | 09/09/22 |
MVM Partners LLP | 10% Owner 10% Owner | Aug 26 | Sell | 18.7775 | 800 | 15,022 | 14,056,592 | 08/30/22 |
MVM Partners LLP | 10% Owner 10% Owner | Aug 24 | Sell | 18.64 | 30,000 | 559,200 | 14,057,392 | 08/26/22 |
MVM Partners LLP | 10% Owner 10% Owner | Aug 15 | Sell | 20.06 | 32,301 | 647,958 | 14,087,392 | 08/17/22 |
Jarboe Matthew | Chief Commercial Off.. Chief Commercial Officer | Aug 11 | Option | 0.6 | 2,878 | 1,727 | 228,173 | 08/15/22 |
Jarboe Matthew | Chief Commercial Off.. Chief Commercial Officer | Aug 11 | Sell | 20.94 | 27,878 | 583,765 | 200,295 | 08/15/22 |
MVM Partners LLP | 10% Owner 10% Owner | Aug 10 | Sell | 20.57 | 144,099 | 2,964,116 | 14,119,693 | 08/12/22 |
MVM Partners LLP | 10% Owner 10% Owner | Aug 08 | Sell | 19.5 | 68,303 | 1,331,908 | 14,263,792 | 08/10/22 |
MVM Partners LLP | 10% Owner 10% Owner | Aug 04 | Sell | 19.32 | 82,100 | 1,586,172 | 14,332,095 | 08/08/22 |
Jarboe Matthew | Chief Commercial Off.. Chief Commercial Officer | Jul 14 | Sell | 19.01 | 86,111 | 1,636,970 | 225,295 | 07/15/22 |
Jarboe Matthew | Chief Commercial Off.. Chief Commercial Officer | Jul 08 | Sell | 19.4433 | 63,889 | 1,242,213 | 311,406 | 07/11/22 |
Bono Frank S. | Chief Technology Off.. Chief Technology Officer | Jun 06 | Sell | 18.74 | 20,000 | 374,800 | 1,661,104 | 06/08/22 |
Bono Frank S. | Chief Technology Off.. Chief Technology Officer | May 27 | Sell | 18 | 25,000 | 450,000 | 1,641,104 | 06/01/22 |